- Home
- GAMB vs WGSWW Comparison
GAMB vs WGSWW Comparison
Compare GAMB & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAMB
- WGSWW
- Stock Information
- Founded
- GAMB 2006
- WGSWW 2017
- Country
- GAMB Jersey
- WGSWW United States
- Employees
- GAMB N/A
- WGSWW 1000
- Industry
- GAMB Services-Misc. Amusement & Recreation
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- GAMB Consumer Discretionary
- WGSWW Technology
- Exchange
- GAMB Nasdaq
- WGSWW Nasdaq
- Market Cap
- GAMB N/A
- WGSWW N/A
- IPO Year
- GAMB 2021
- WGSWW N/A
- Fundamental
- Price
- GAMB $8.31
- WGSWW $0.08
- Analyst Decision
- GAMB Strong Buy
- WGSWW
- Analyst Count
- GAMB 8
- WGSWW 0
- Target Price
- GAMB $15.38
- WGSWW N/A
- AVG Volume (30 Days)
- GAMB 629.6K
- WGSWW 36.6K
- Earning Date
- GAMB 11-13-2025
- WGSWW 02-18-2025
- Dividend Yield
- GAMB N/A
- WGSWW N/A
- EPS Growth
- GAMB N/A
- WGSWW N/A
- EPS
- GAMB 0.40
- WGSWW N/A
- Revenue
- GAMB $147,655,000.00
- WGSWW $305,450,000.00
- Revenue This Year
- GAMB $38.38
- WGSWW N/A
- Revenue Next Year
- GAMB $11.89
- WGSWW N/A
- P/E Ratio
- GAMB $20.89
- WGSWW N/A
- Revenue Growth
- GAMB 27.57
- WGSWW 50.79
- 52 Week Low
- GAMB $7.93
- WGSWW $0.17
- 52 Week High
- GAMB $17.14
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- GAMB 40.63
- WGSWW N/A
- Support Level
- GAMB $7.94
- WGSWW N/A
- Resistance Level
- GAMB $8.17
- WGSWW N/A
- Average True Range (ATR)
- GAMB 0.23
- WGSWW 0.00
- MACD
- GAMB 0.09
- WGSWW 0.00
- Stochastic Oscillator
- GAMB 44.44
- WGSWW 0.00
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.